Home
About
Overview
Sharing Data
ORCID
Help
History (33)
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease.
Hypoxic-Preconditioned Bone Marrow Stem Cell Medium Significantly Improves Outcome After Retinal Ischemia in Rats.
A practical approach to positioning therapies in ulcerative colitis.
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
Vedolizumab in the treatment of Crohn's disease.
See All 33 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab in the treatment of Crohn's disease.
Vedolizumab in the treatment of Crohn's disease. Expert Rev Gastroenterol Hepatol. 2016; 10(3):283-90.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
Crohn Disease
Gastrointestinal Agents
Humans
Integrins
Remission Induction
Treatment Outcome
authors with profiles
David Rubin